A02-RFI for SAM MMCIP.pdf

REQUEST FOR INFORMATION (RFI)

for

MINIATURIZED LARGE VOLUME INFUSION SYSTEM

THIS IS NOT A REQUEST FOR PROPOSALS (RFP) OR A REQUEST FOR

QUOTATIONS (RFQ); IT IS STRICTLY A REQUEST FOR INFORMATION (RFI).

NEITHER UNSOLICITED PROPOSALS NOR ANY OTHER KINDS OF OFFERS WILL

BE CONSIDERED IN RESPONSE TO THIS RFI. NO CONTRACT/ORDER WILL BE

AWARDED PURSUANT TO THIS ANNOUNCEMENT.

Disclaimer: The purpose of this RFI notice is to gain market knowledge. This notice does not obligate the Government to award a contract/order or otherwise pay for the information provided in response. The Government reserves the right to use information provided by respondents for any purpose deemed necessary and legally appropriate.

Any organization responding to this notice should ensure that its response is complete and sufficiently detailed to allow the Government to determine the organization's solution and qualifications to perform the work. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. After a review of the responses received, a synopsis and/or solicitation may or may NOT be published at a future date and time.

1.0 RFI Number: HT9425-25-RFI-MMCIP

2.0 RFI Issuing Office: United States Army Medical Research Acquisition Activity

(USAMRAA)

3.0 RFI Issue Date: 28 FEB 2025

4.0 RFI Title: Miniaturized Large Volume Infusion System

5.0 Agency: Defense Health Agency (DHA)

6.0 Office: Program Executive Office Operational Medical Systems (OPMED) (Warfighter Expeditionary Medicine and Treatment (WEMT) Project Management Office

(PMO)

7.0 Location: Frederick, MD (on Fort Detrick)

8.0 Contract Type: Unknown

In accordance with Federal Acquisition Regulation (FAR) 15.201 "Exchange with industry before receipt of proposals," this RFI is for information and planning purposes only at this time and shall not be construed as a solicitation or as an obligation on the part of the Unites States Army Medical Research and Development Command (USAMRDC), USAMRAA, USAMMDA, The Defense Health Agency (DHA) or any collaborative Department of Defense (DoD) activities.

This RFI is for information and planning purposes only and is neither to be construed as a commitment by the Government nor will the Government pay for information solicited.

Respondents are solely responsible for all expenses associated with responding to this RFI. No evaluation letters and/or results will be issued to the respondents. Currently, no solicitation exists; therefore, please do not request a copy of the solicitation. NO

PHONE CALLS WILL BE ACCEPTED OR RETURNED.

Neither unsolicited proposals nor any other kind of offers will be considered in response to this RFI. Responses to this notice are not offers and will not be accepted by the Government to form a binding contract. In keeping with the standards of FAR Part 10, the Government may request additional information from responders. Responders are solely responsible for all expenses associated with responding to this RFI or any follow-up information request. All information received in response to this RFI or any follow-up information request that is marked Proprietary will be handled accordingly. Responses to the RFI will not be returned. At this time, questions concerning the composition and requirements for a future request for proposal will not be entertained.

9.0 Background: The Government is conducting market research to determine whether a commercial solution can be provided to meet requirements for a miniaturized large volume infusion system.

This market research may also assist with the further development and/or refinement of the requirements.

10.0 Objective and Purpose/ Scope: The capability desired is a miniaturized large-volume infusion system capable of delivering multiple fluids, medications, nutrition, and blood products through 3-4 channels. The form factor of the system could be either integrated or a modular system. Innovative solutions are welcome. Ideally, the system will include the ability to control all channels using a single screen/control interface.

However, alternative solutions with low size and weight may fit the need. The system is intended to be used by the military in austere locations, including en route care (ERC).

However, the end product will also need to be a commercially viable system with sufficient demand in the civilian sector to sustain its availability.

11.0 North American Industry Classification System (NAICS) Code:

Unknown

12.0 RFI Attachments: The following documents are attached to the RFI o Attachment 1: Minimum Essential Characteristics (MECs) o Attachment 2: Company & Product Information

13.0 Response Due Date: Interested parties shall submit the RFI response electronically by 4:00pm Eastern on Friday, 28 March 2025 via e-mail to:

Katherine Ramsburg at: katherine.j.ramsburg.civ@health.mil Email Subject/title: "RFI response for HT9425-RFI-25-MMCIP”

14.0 SUBMISSION INSTRUCTIONS:

14.1 The Government appreciates responses from ALL capable and qualified sources, especially small businesses.

14.2 Interested firms should submit a response that demonstrates the Respondent's ability to perform the scope of work identified in this RFI.

14.3 Format specifications include Arial 12-point font, single spaced, single sided, 8.5 by 11- inch paper with 1-inch margins. All submissions shall be made electronically (as described above) and be in one of the following formats: Microsoft Word or searchable Adobe PDF.

Responses should adhere to the following formatting and outline instructions:

Cover Page (1 page)

• Title

• Organization

• Responders technical and administrative points of contact (names, addresses, phone, and email addresses)

• Topic area: "MMCIP”

14.4 Completed Attachment 1 and Attachment 2 and Company’s specifications sheet

15.0 Confidentiality: All 'Proprietary', 'Classified', 'Confidential', or 'Sensitive' information shall be marked as such and will be treated accordingly. The Government reserves the right to use any non-proprietary technical information in any resultant solicitation(s).

(End of RFI) mailto:katherine.j.ramsburg.civ@health.mil